Laser photoablation of pathological endocardium: in vitro findings suggesting a new approach to the surgical treatment of refractory arrhythmias and restrictive cardiomyopathy.
In selected patients, malignant ventricular tachyarrhythmias have been successfully abolished by excision of subendocardial arrhythmogenic foci. Likewise, in certain patients in whom restrictive cardiomyopathy is due to endocardial thickening, endocardial resection has resulted in hemodynamic improvement. The present study was designed to explore the utility, in vitro, of laser photoablation of pathologically thickened endocardium. Endocardial photoablation was easily accomplished regardless of etiological or anatomical variations using either the focused beam of a carbon dioxide laser or argon laser light delivered through a 200-microns optical fiber. Photoablation of areas as large as 3.9 X 1.3 cm was performed within 40 seconds. The extent or depth of endocardial photoablation could be limited to 2 mm2 in area or 1 mm in depth using either form of laser therapy. These in vitro results suggest that either carbon dioxide or argon laser phototherapy can be successfully applied to the surgical treatment of refractory arrhythmias and restrictive cardiomyopathy. Advantages of laser photoablation include speed and precision. Furthermore, laser photoablation obviates the difficulty associated with conventional techniques in establishing tissue planes.
D001128:Argon; D001145:Arrhythmias, Cardiac / Q000473:pathology / Q000601:surgery*; D002245:Carbon Dioxide; D009202:Cardiomyopathies / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D004699:Endocardium / Q000473:pathology / Q000601:surgery*; D004719:Endomyocardial Fibrosis / Q000150:complications / Q000473:pathology / Q000601:surgery; D006801:Humans; D066298:In Vitro Techniques; D053685:Laser Therapy
D002245:Carbon Dioxide; D001128:Argon